An investigation into Reuters leadership reveals that CEO Thomas Glosser is a director of Merck & Co. and a member of the Council on Foreign Relations (CFR). He also participates in the World Economic Forum in Davos. The hosts argue that these elite connections create inherent conflicts of interest in the news agency's reporting on pharmaceuticals and global policy.
